| The
achievement of AidooAid, an
enviable milestone in man's quest to grow hair back on receding
hairline, balding hair--and, alopecia generally, including premature
hair loss; is one which has propelled this great scientist, inventor,
pioneer and educator: Professor Frank Aidoo into the arena of world
recognition. The
following are some of the many letters sent to doctors and scientist
around the world to introduce the achievement of AidooAid :
L
Aidoo International
Research & Marketing Inc.,
360 S. Milliken Ave, Suite G, Ontario CA. 91761
Tel: (909) 605 7788 Fax: (909) 605 7789
David Kessler, M.D. April
26, 1996-2000
Commissioner: Food & Drug Administration,
5600 Fishers Lane,
Rockville, MD 20857-001
Dear Dr. Kessler,
Re: AidooAid
The Bald No More System.
This is my second letter
to you exactly two years todate; on the above product--the end
result of my 20 years of research work.
I am a research scientist
in the field of Enzymes and Alkaloids. My work has led to the
discovery of 35 virgin formats of enzymatic traits, and 12 master
alkaloids pre-emptors of invaluable accord to humankind...
In my letter of April
22, 1994, I contested the ruling you made in January 1990 concerning
Rogaine. The assertion was unequivocal in your statement. It was
that--and I quote: " Rogaine with 2% minoxidil is the only product
proven to stimulate hair growth." un quote.
The above ruling is what
led me to write you the letter referred to above; of which I am
enclosing a copy; and other scientific data collected over the
years legitimizing in total--the statement: AidooAid The Bald
No More System actually grows hair!...And that it grows hair on
sufferers of alopecia, including arieta, totalis and androgenetica.
(commonly known as male and female pattern baldness). And unlike
Rogaine, it has no side effects; and it grows hair on all areas
of the head -- not the vertex area alone, but also frontal and
what I call "annexal areas and patches."
I had included the pictorial
documentation to accent the uniqueness of my work.
Your action has led to
a state within which my life’s work was deduced to "semi-fraud"
in the face of those who heard our claim that: AidooAid
actually grows hair!
In spite of the fact
that I sent you all this information, your department was aware
of this breakthrough sometime back in June 1992, in which an article
was written about my work in the Sun Telegraph newspaper of San
Bernardino, California; and an interview with The Los Angeles
Times.
Before publication, your
office was contacted and a statement relayed to the above newspaper
by your west coast bureau spokesperson: Mike Shaffer, conceded
to our validity, and yet, there was no attempt on your part to
redress or rescind your statement.
Rogaine has been proven
not to grow hair as ascribed by your office... It is ineffective,
and by that dimension, has destroyed the public’s view and perception
toward legitimate claims such as ours. It cannot grow--and this
is for refutation purposes: one hundred th of hair AidooAid
is capable of... AidooAid
does not stimulate hair growth as asserted by Rogaine’s outlay...
It actually re-activates the dormant hair follicles to grow hair
again!...And it does not take 4 months or longer like Rogaine:
...The fact that it works with the follicles, the re-activation
becomes evident within two to three weeks upon use, sometimes
before! And being arranged with an organic coenzs, the new hair
does not fall "off" with reduction or cessation of use. And therefore,
unlike Rogaine, it is not a lifelong proposition...You have all
this, including all the pertinent scientific data on your record!
My work has revealed
that there is an unnatural membrane which I call: gHanape-bio.
It grows to hinder--restricting the "free flow" of sebumatic factors
to the follicles. Once the gHanape-bio is debased, the follicle(s)
assume accord of viability--growing hair again into its anagenic
state.
I love
America, and I want America to benefit from my findings and discoveries.
And as a scientist, there have been times when I have thought
of selling/transferring my work to other nations and pharmaceutical
companies... In essence, offer them the leadership in this arena.
I need to be accorded
a reply to this my second letter; to which copies are also sent
to the names enumerated below.
Sincerely,
Frank Aidoo. Ph.D
Enzyme & Alkaloids Research Scientist
cc. News Editor CNN cc.
Editor: New York Times
cc. Editor: Washington Post cc. American Academy of Dermatology
cc. Governor Pete Wilson. cc. Mike Shaffer, West Coast office
FDA

OCT 21 1997
Frank Aidoo
Ph.D,
601 S. Milliken Avenue Suite P Ontario,
California 91761
Dear Dr. Aidoo:
This is in
response to your letter of July 27, 1997, to Senator John McCain
regarding your product AidooAid. Senator McCain requested that
we respond directly to you.
According to
your letter, two previous letters you sent the Food and Drug Administration
(FDA or the Agency) were not answered. We want you to know that
the Agency has no record of having received these letters, and
we are sorry for the frustration you have experienced in not receiving
answers.
From the information
provided in your letter, we believe your product has the potential
to be considered a drug under the provisions of sections 201(g)
and 201(p) of the Federal Food, Drug, and Cosmetic (FDC) Act (pertinent
sections enclosed) which define what is considered a drug under
the law. Also enclosed is a copy of section 310.527 of Title 21
of the Code of Federal Regulations (CFR). This section provides
information on products for hair growth or hair loss prevention
FDA regulates
the manufacture, sale, and distribution of drugs in the United
States under the authority of the FDC Act, and reviews the data
included in New Drug Applications (NDAs) that are submitted for
approval. Enclosed is a copy of an FDA consumer special report
entitled "From Test Tube to Patient: New Drug Development in the
United States." This report will provide a general overview of
the drug development process. After reading this report, you may
wish to refer to the FDC Act and Title 21, CFR from the Government
Printing Office (GPO). These references contain information such
as regulatory definitions and the data needed to support an approval
of an NDA and marketing regulations (there will be a charge for
these manuals). Title 21, CFR is available through our website
at: www.fda.gov/cder. Select the "Regulatory Guidance" icon, then
select "Title 21, Code of Federal Regulations." You may also wish
to visit your local library and consult these references. Finally,
you can purchase copies through GPO. The GPO can be reached at
the following phone number and address:
The Government
Printing Office Superintendent of Documents
Attention: New Orders
P.O. Box 371954 Pittsburgh,
Pennsylvania 15250-7954
Phone: (202) 512-1800 Fax: (202) 512-2250
If you decide
to pursue the development of these products, you can contact the
Drug Information Branch and request an Investigational New Drug
(IND) package. The Drug Information office can provide information
on any organizations, grants, or other agencies that assist small
drug businesses. If you wish to contact them, they can be reached
at the following phone number and address:
Food and Drug
Information (HFD-210) 5600 Fishers Lane
Rockville, Maryland 20857
Phone: (301) 827-4573
For information
on user fees, please contact the Office of External Affairs, Industry
Liaison Staff at (301) 827-3430. They can send you a package that
contains all of the current information on user fees. Please note
that small businesses can apply for a user fee exemption.
We hope this
information is helpful.
Sincerely Diane
E. Thompson
Associate Commissioner for Legislative Affairs
3 Enclosures
Section 201 FDC Act 21 CFR section 310.527 FDA Consumer,
"From Test Tube to Patient"
July 27, 1997
Senator John McCain,
Chairman U.S. Committee on Commerce,
Science & Transportation.
Washington DC.
Dear Senator,
AidooAid:
A Scientific Breakthrough
As per my e-mail of July
27, 1997, I hereby enclose the pertinent documents I advised will
be sent under a separate cover.
I take this moment to thank
you in advance for the speedy attention offered to my e-mails.
Again, thank you.
Sir, as the attached letter
(copy) sent to the then Commissioner of FDA Dr. David Kessler
will show, I am a research scientist in the field of Enzyme and
Alkaloid. My work has lead to the discovery of 35 newly
formatted Enzymes; and 12 Virgin Alkaloids of unparalleled importance
within the medium of science.
I have unraveled and utilized
the virtues coherent within one Enzymatic base--and supported
it with an adjunct (co-enzyme) in an empirical scientific arrangement
to achieve a breakthrough in the "re-activation" of
the dormant hair follicles to GROW HAIR again! ...Being that this
order of achievement is organic in it's accentuation, it grows
hair on all types of hair, and does not produce any side effects.
...Within some of my other
prevailing base(s) of Enzymes and Alkaloids--all being proprietary
with legible style of conduction, there exist discoveries bearing
composers of other biological effusers capable of suppressing
and normalizing--in some cases: "idiopathic" human abnormalities
and diseases.
Over 5 years ago, a local
newspaper hearing of my work sent a team to cover it. (Sun Telegraph
of San Bernardino, California). Being that the FDA had asserted
there was nothing but Rogaine--a product serendipitously discovered,
and fundamentally a Drug for the controlling of hypertension--and
marked as a topical "hair growing" product, I requested
the Commissioner to rescind his words; or investigate my claim.
I have spent over 20 years in this field of research--collecting
data pictorially; and studying the different forms of alopecia
left to conjecture within the scientific community...of which
I have tonated usable terminology for their identification.
I submitted my work to AMA
and over 1000 physicians in the field of dermatology; including
notable medical schools; and have been shunned due to the statement
made by the then commissioner in 1991 concerning Rogaine.
On two consecutive times,
I wrote Dr. Kessler providing him with all the necessary information
for revision; with no acknowledgement or reply resulting...
Sir, I believe that America
being the world leader within the field of science can only hold
on to it's leadership when people like myself are accorded due
recognition and equity--even in science; especially, when I hold
the secret to this phenomenon...including others yet to be revealed.
My request is based on the
fundamental truth--which we all seek for: especially when a statement
is antithesis to the prevailing in science. Sir, I have
provided all the pre-requisite needed for revisiting the Commissioner's
statement; and have also written to Governor Pete Wilson of California--as
I reside in his state (copy attached).
I have since then received
an unceremonious visit by an individual who announced himself
as an FTC agent, who, after seeing the postings of documents and
pictures of "before and after" of some users in my office,
has failed to "officially" announce his findings.
Sir, I wish and request
that your office and chair investigate what I have brought before
you. In a country where innovation and creativeness are
encouraged, I can only site a scenario of inadvertency on Dr.
Kessler's part; because, by all account--notwithstanding the scientific
and pictorial submitted, the statement made in his capacity, clearly,
legitimized Rogaine with monopolistic stripes: an official
rubber stamp--in essence, in an industry where they have not been
able to show any "scientific-pictorial" proof:; especially,
when the statement was with all accord of conviction and honesty
of an FDA Commissioner.. Unfortunately, the said product (Rogaine)
has since failed to live up to it's relish: Based on what I have
submitted, and by virtue of the fact that my work has global connotation
and meaning, that, I be accorded an investigation into my citation...
I am yours sincerely,
Frank Aidoo Ph.D.
*Sir, my work is posted
on the internet--with the world wide address:
www.aidooaid.com
This information and
other may be accessed; and are for your perusal...
cc: Committee
Members
Senators:
|
Ted
Stevens, Alaska
Conrad Burns, Montana
Slade Gortan, Washington
Trent Lott, Mississippi
Kay Bailey Hutchison, Texas
Olympia J. Snowe, Maine
John Ashcroft, Missouri
William Frist, Tennessee
Spencer Abraham, Michigan
Sam Brownback, Kansas
|
Senators:
|
Ersnest
F. Hollings, South Carolina
Daniel K. Inouye, Hawaii
Wendell H. Ford, Kentucky
John D. Rockefeller IV, West Virginia
John F. Kerry, Massachusetts
John B. Breaux, Louisiana
Richard H. Bryan, Nevada
Byron L. Dorgan, North Dakota
Ron Wyden, Oregon |
Enc:

COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION
WASHINGTON, DC 20510-6125
August 18,
1997
Mr. Frank Aidoo
Aidoo International 601 S. Milliken Ave.,
Suite P Ontario, CA 91761
Dear Mr. Aidoo:
Thank you for your letter regarding Aidoo Aid and the enzyme and
alkaloid research that you have been conducting. I am always glad
to have the opportunity to be of assistance
I have contacted the Associate Commissioner for Health Affairs
at the Food and Drug Administration about the difficulty that
you have encountered with Aidoo on your behalf. I have asked for
a prompt response to be sent directly to you.
Please do not hesitate to contact me if you have any further questions
or comments.
Sincerely,

John McCain
Chairman
JM/bm
Diane E. Thompson,
Associate Commissioner for Legislative Affairs,
U.S. Food & Drug
Administration,
Rockville, MD 20857
Dear
Ms. Thompson.
Re: AidooAid
I have received your letter
of October 21, 1997, in answer to one on my behalf from Senator
John McCain: the chairman of the U.S. Committee on Commerce, Science
and Transportation.
I was taken “aback”
by inference that you did not receive my letter sent to the department—addressed
to the former commissioner Dr. David Kessler.
To establish the viability
of my letter, I enclose herewith the “return receipt” of delivery
from the U.S. Postal Service.
In reading your response,
I notice the “theme” of my letter—the contention and the essence
of it—being the statement made by the then commissioner that Rogaine
is the only product proven to grow hair was not addressed.
As I commented, the statement
was emphatical, very conclusive. It appeared to have represented
the totality of scientific motion, and as such resonated across
the GLOBE—measuring with his stand as the Commissioner of Unite
States Food & Drug Administration (FDA).
Ms. Thompson, the fact of
the matter is: my 12 year old son and his classmates cannot understand
why they clearly see in accord ’hair’ on PEOPLE WHO DID NOT HAVE
HAIR, (after examining pictures/data of users of AidooAid and
meeting some…) but are in essence accosted to disregard
the prevailing, and are to adopt words of a trusted keeper of
United States government—totally inconsistent—and at odd with
what they clearly see with their reasoning: It demarcates
their understanding; and are left confused and frustrated!
--Pertaining to classification
of products, my research which covered more than 20 years, also
measured the categories under which “cosmetics and natural based”
products are augmented under the laws of the United States as
enumerated under the FDA guidelines.(By your suggestion, I
have re-visited them thoroughly—concentrating on the define of
“herbal,” as the base of my work fits more under this category.)
AidooAid is a “scientific
breakthrough” that uses a NON-DRUG base! And are unlike “drug”
based products such as Minoxidel (Rogaine by Upjohn), and Finasteride
(Merck’s Proscar), a drug awaiting your conferation.
Science, I believe, and
trust you will agree is still evolving. It does not have
answer(s) to all our ill(s) and will never. Your inversion
that it is only “drug” that has the ability to grow hair has no
bases; and by the data and support I have collected to date deems
that adage to be totally false. My work therefore, has made
such theory held before the emergence of AidooAid obsolete, since
the “proof and evidence” presented cannot be refuted.
At this state, I request
as a matter of scientific fact, that, a statement be made to the
effect that AidooAid has the ability to re-activate the “dormant
hair follicle” to grow hair again…and more so that Rogaine or
Finasteride; and without any of the side effects; being that it
utilizes “a breakthrough” catelization of enzymatic order, to
which the data and pictorial submitted to date suffice…
As I stated in my letter
to the Senator—in his esteem capacity, I believe this great NATION
called America epitomizes progress and truth; and I also believe
your department was requested to answer my citation. This
warrants clarification in view of the fact that AidooAid grows
hair…and achieves an unprecedented result, far capable than any
product out in the market (being those bearing activance of Drug,
OTC, Homeopathic or botanical/herbal preparation).
As you may have
seen the pictorial data presented on our internet site, AidooAid
grows hair on sufferers of male and female pattern baldness
(Androgenic Alopecia).
It stops hair loss; and unlike the others, it works well
on both frontal and vertex hair loss; and being that the base is
organic in composition, when a user discontinue its use after he/she
has grown their hair back, the hair does not fall out! …This is
achieved because of the fact that it is not a drug like Minoxidel
or Finasteride where cessation of use denotes resumption of hair
loss…and is meant therefore to be used indefinitely.
–They are drugs! —And as such unnaturally cajoles/stimulates
growth: usually “vellus” hair growth, while AidooAid facilitates
the “dormant hair follicle” to use its own chemistry to grow hair
back naturally—resulting in the pictorial and data posted: one that
cannot be duplicated using any DRUG-BASED PRODUCT. I
have posted documents detailing my work including over one hundred
pictorial data substantiation its efficacy. It should also be conferred
that my work is a BREAKTHROUGH IN THIS FIELD OF SCIENTIFIC RESEARCH
and REASONING, and for the sake of human progress should be embraced.
As an empiricist, it would be appropriate to understand that my
theory and its format are markedly antithesis to the prevailing,
as it further enhances man’s ability to redress some of the “idiopathic”
complexities from a different angle: such as the one used in achieving
the results I have presented including others yet to be revealed…
I look forward to your certain reply.
Frank
Aidoo Ph.D
cc:
Senator John McCain


January 5,
1998
Frank Aidoo,
Ph.D.
Aidoo Internation Research & Marketing, Inc.
601 S. Milliken Avenue, Suite P
Ontario, CA 91761
Dear Dr. Aidoo:
I am responding
to your November 17, 1997, letter to Diane Thompson at the Food
and Drug Administration regarding your product AidooAid. Your
letter has been referred to the Center for Drug Evaluation and
Research for a reply.
As stated in
Ms. Thompson's October 21, 1997, letter to you, we consider your
product to be a drug under the provisions of section 201(g) and
201(p) of the Federal Food, Drug, and Cosmetic Act, therefore
the product may not be legally marketed unless the product has
an approved New Drug application (NDA). Further, regulation coveing
hair growht products in Part 310.527(b) (copy enclosed) of Title
21 of the Code of Federal Regualations (21 CFR) state:
"(b) Any
OTC drug product that is labeled, represented , or promoted for
external use as a hair grower or for hiar loss prevention is regareded
as a new drugh within the meaning of section 201(p) of the Federal
Food, Drug, and Cosmetic Act (the act), for which an approved
new drug application under section 505 of the act and part 314
of this chapter is required for marketing. In the absence of an
approved new drug application, such product is also misbranded
under section 502 of the act."
We are sending,
under separate cover, the document and forms for filing an NDA.
The NDA must contain adequate data, including clinical trials,
which establish that the drugs is safe and effective for the intended
use. This is the process of proving that your product is effective,
which has been the focus of your letter. The regualtions covering
the NDA process are found in 21 CFR 312 and 314. The agency will
be more that willing to review your new drug application and clinical
data supporting claims of safety and efficacy for the AidooAid
product. Once a completed new drug application is received we
can begin the review process of your product. If you need additional
guidance documents pertaining to submission of a new drug application
please request them from our Drug Information Branch at 301-594-4573.
Sincerely yours,
Celia A. DeLawter
Executive Secretartiat
(HFD-6)
Center for
Drug Evaluation and Research
Letter
to Doctors:
Aidoo International Research
& Marketing Inc.,
360 S. Milliken Ave, Suite G,Ontario, CA. 92761.
Tel: (909) 605 7788 Fax: (909) 605 7789.
Dear Dr.
Re: AidooAid
The Bald No More System.
This letter is to introduce
you to a "new" discovery -- an all natural base of Enzyme and
Alkaloids with the ability to "re-activate" the dormant hair follicles
to grow hair again.
A breakthrough discovery
by Frank Aidoo. Ph.D., a Research Scientist in the field of Enzyme
and Alkaloids. ...An empirical work spanning over 20 years in
isolation and circumscription has led to this find: an organic
catalyst of an enzymatic order -- punctuated with co-enzymes of
"newly" discovered alkaloidic property to re-activating the "dormant
hair follicles" to grow hair again into its anagenic state.
The result, therefore,
is a product that elicits growth (of hair) on sufferers of: Alopecia:
(arieta, totalis or androgenic).
Arranged under a newly
isolate vertex of covalency, it provides all the natural composites;
including proteinic virtues to build triapite sebumatic factors
to yield growth.
...Compounded with natural
composites, there are fewer denaturing within the base; resulting
therefore, in a predictable hair growth in 99.9% of cases of those
who suffer with arieta, totalis and infantal androgenetica. Unlike
Rogaine -- composite of minoxidil; AidooAid
The Bald No More System elicit vertex and frontal (receding hairline)
growth; including q/marks and annexial patches.
It also has no side effects;
and being biologically semblance to the requisite of the follicle’s
traits, once the individual has achieved the result needed, he/she
could switch to our Phase2 formula: the maintenance kit.
Using AidooAid,
therefore, is not a life long proposition. The new hair also remains
with all the attributes of anagency...as nature then recur itself!
This product has gone
through all rigor: and is marketed unequivocally as "hair growing
product." It is also a breakthrough known to the FDA, including
other agencies.
We are enclosing herewith:
other scientific documentation (in the form of pictures of: before
and after of some users). You will also notice there has been
some news coverage (investigative) by some respectable newspapers
here in California. We enclose also price list, and a poster for
your office.
Thank you.
Harold "HK" Kennedy,
Physicians Marketing Director.
HK/cc
***enc.
|